Aegea for Patients

Inspiring new approaches to women’s healthcare

  • AEGEA Medical Secures $40 million Financing

    REDWOOD CITY, CA, Jan 2, 2018 – AEGEA Medical Inc. (“AEGEA”), a privately held medical technology company in the women’s health space focused on the development of its patented Adaptive Vapor Ablation technology for endometrial ablation, today announced it has closed on a $30 million financing with Perceptive Advisors (“Perceptive”). In connection with the financing,… Read More

  • AEGEA Medical Announces U.S. FDA Approval of the AEGEA Vapor System(TM) with Adaptive Vapor Ablation for the Treatment of Menorrhagia

    REDWOOD CITY, CA, November 13, 2017 – AEGEA Medical, Inc., a privately held medical device company focused on the development of its patented Adaptive Vapor Ablation technology, today announced U.S. FDA approval of the AEGEA Vapor System as a new treatment option for menorrhagia. The AEGEA Vapor System is the first endometrial ablation system specifically designed for use in… Read More

  • AEGEA Medical Announces Series C Financing and Completion of Pivotal Trial Enrollment

    Redwood City, CA, USA (May 4, 2015) – AEGEA Medical, Inc., a privately held medical device company focused on the development of its proprietary and innovative water vapor treatment for abnormal uterine bleeding, today announced the closing of its Series C financing of $36 million with investments from existing investors Alloy Ventures, Delphi Ventures, and Covidien/Medtronic…. Read More

A natural choice. A new freedom.